Search Results - "Borin, Lorenza"
-
1
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
Published in The New England journal of medicine (24-12-2020)“…Older patients with acute myeloid leukemia were treated with intensive chemotherapy and then randomly assigned to receive placebo or oral azacitidine (CC-486)…”
Get full text
Journal Article -
2
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Published in Journal of clinical oncology (10-04-2021)“…Recurrently mutated genes and chromosomal abnormalities have been identified in myelodysplastic syndromes (MDS). We aim to integrate these genomic features…”
Get full text
Journal Article -
3
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia
Published in Scientific reports (28-01-2021)“…Hematologists are frequently involved in the diagnostic pathway of Gaucher disease type 1 (GD1) patients since they present several hematological signs…”
Get full text
Journal Article -
4
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
Published in Platelets (Edinburgh) (31-12-2024)“…Acquired Aplastic Anemia (AAA) is a rare disease involving primary bone marrow failure with consequent pancytopenia. The addition of the synthetic…”
Get full text
Journal Article -
5
Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment
Published in PloS one (18-07-2019)“…Chronic myeloid leukemia (CML) is characterized by the constitutive tyrosine kinase activity of the oncoprotein BCR-ABL1 in myeloid progenitor cells that…”
Get full text
Journal Article -
6
Valproic Acid at Therapeutic Plasma Levels May Increase 5-Azacytidine Efficacy in Higher Risk Myelodysplastic Syndromes
Published in Clinical cancer research (01-08-2009)“…Purpose: Epigenetic changes play a role and cooperate with genetic alterations in the pathogenesis of myelodysplastic syndromes (MDS). We conducted a phase II…”
Get full text
Journal Article -
7
Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an “Old‐fashioned” Drug be Effective?
Published in HemaSphere (01-04-2023)Get full text
Journal Article -
8
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: Kinetics of its appearance and potential predictive role in infectious complications
Published in Leukemia research (01-01-2015)“…Highlights • Intensive chemotherapy causes the appearance of NTBI, independently from transfusions. • Formation of NTBI is a consequence of chemotherapy…”
Get full text
Journal Article -
9
-
10
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID‐19 vaccine: A single‐center prospective observational study (NCT05074706)
Published in EJHaem (01-11-2022)“…Hematological patients at higher risk of severe COVID‐19 were excluded from the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine trials. In…”
Get full text
Journal Article -
11
A CASE OF ATYPICAL PROLONGED HEMATOLOGIC TOXICITY WITH AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML), REVIEW OF LITERATURE AND A PROPOSAL OF MANAGEMENT
Published in Mediterranean journal of hematology and infectious diseases (01-03-2012)“…Hypomethylating drugs are useful and approved in the management of myelodysplastic syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). However, phase 2…”
Get full text
Journal Article -
12
Iron toxicity – Its effect on the bone marrow
Published in Blood reviews (01-11-2018)“…Excess iron can be extremely toxic for the body and may cause organ damage in the absence of iron chelation therapy. Preclinical studies on the role of free…”
Get full text
Journal Article -
13
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Published in Journal of clinical oncology (20-05-2023)“…Myelodysplastic syndromes (MDS) are heterogeneous myeloid neoplasms in which a risk-adapted treatment strategy is needed. Recently, a new clinical-molecular…”
Get full text
Journal Article -
14
Efficacy and Safety of Danazol in Patients with Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms: A Multicenter Observational Study
Published in Blood (15-11-2022)Get full text
Journal Article -
15
High-Risk Population Screening for Gaucher Disease: Final Results and Key Learnings from an Italian Multicenter Observational Study
Published in Blood (05-11-2020)“…▪ Background:Gaucher disease (GD) is an autosomal recessive lysosomal storage disorder due to the deficiency of beta-glucosidase enzyme. Its prevalence in the…”
Get full text
Journal Article -
16
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study
Published in The oncologist (Dayton, Ohio) (22-05-2024)“…When a hematological malignancy is diagnosed, the whole family carries the burden of the disease; parents often try to protect minor children from suffering by…”
Get full text
Journal Article -
17
Retaining Parental Role Despite the Presence of Hematological Neoplastic Diseases: The Emanuela Project and the Role of the Hematologist
Published in Blood (29-11-2018)“…Introduction The diagnosis of a hematological neoplastic disease (HND) bears a great impact on the patient family, which suffers abrupt changes in living…”
Get full text
Journal Article -
18
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
Published in Leukemia research (01-07-2022)“…Acute myeloid leukemia (AML) identifies a heterogeneous group of clonal disorders, both clinically and genetically. A large number of mutations have been…”
Get full text
Journal Article -
19
Patient‐reported outcomes enhance the survival prediction of traditional disease risk classifications: An international study in patients with myelodysplastic syndromes
Published in Cancer (15-03-2018)“…BACKGROUND Current prognostic systems for myelodysplastic syndromes (MDS) are based on clinical, pathologic, and laboratory indicators. The objective of the…”
Get full text
Journal Article -
20
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
Published in European journal of haematology (01-06-2014)“…Background In the absence of randomized, controlled trial data to support iron chelation therapy in transfusion‐dependent patients with myelodysplastic…”
Get full text
Journal Article